Clinical Trial Update: Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective [Phase 1]

View source ↗

Summary

Clinical trial update indicating completion of a Phase 1 multiple ascending dose study evaluating safety, tolerability, and pharmacokinetics of AMG 581 in healt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• AMG 581

Snippet

Sponsor: Amgen | Conditions: Schizophrenia or Schizoaffective Disorder | Phase 1 | Status: COMPLETED